Novavax Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
Forward P/E10.4610.88
P/S Ratio1.890.580.459.448.58
P/B Ratio-2.06-0.80-1.39-30.766.50
Price/Tangible Book8.39
Price/FCF40.30
Price/OCF33.50
Enterprise Value Ratios
EV/Revenue0.940.180.158.158.89
EV/FCF34.79
Profitability & Returns
Return on Equity (ROE)-12.66%-1.90%
Return on Assets (ROA)-0.09%-0.17%-0.17%-0.51%-0.29%
Return on Capital Employed (ROCE)-0.57%-3.40%3.20%-9.05%-0.41%
Leverage & Solvency Ratios
Debt/Equity-0.42-0.39-0.97-1.490.77
Debt/FCF1.95
Liquidity Ratios
Current Ratio0.980.700.690.902.15
Quick Ratio0.890.530.580.821.68
Efficiency Ratios
Asset Turnover0.410.480.820.550.54
Inventory Turnover22.5926.4790.94
Yield & Distribution Ratios
Earnings Yield-0.15%-0.96%-0.74%-0.16%-0.10%
FCF Yield-0.08%-1.35%-0.57%0.02%-0.02%
Buyback Yield-0.51%-0.29%-0.05%-0.29%-1.39%